ATE209191T1 - Parazinon thrombin inhibitoren - Google Patents

Parazinon thrombin inhibitoren

Info

Publication number
ATE209191T1
ATE209191T1 AT97918780T AT97918780T ATE209191T1 AT E209191 T1 ATE209191 T1 AT E209191T1 AT 97918780 T AT97918780 T AT 97918780T AT 97918780 T AT97918780 T AT 97918780T AT E209191 T1 ATE209191 T1 AT E209191T1
Authority
AT
Austria
Prior art keywords
parazinone
thrombin inhibitors
thrombin
inhibitors
compounds
Prior art date
Application number
AT97918780T
Other languages
English (en)
Inventor
Philip E Sanderson
Terry A Lyle
Bruce D Dorsey
Richard J Varsolona
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9609714.2A external-priority patent/GB9609714D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE209191T1 publication Critical patent/ATE209191T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT97918780T 1996-04-23 1997-04-18 Parazinon thrombin inhibitoren ATE209191T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US1604196P 1996-04-23 1996-04-23
GBGB9609714.2A GB9609714D0 (en) 1996-05-09 1996-05-09 Pyridinone thrombin inhibitors
US4300997P 1997-04-14 1997-04-14
PCT/US1997/006744 WO1997040024A1 (en) 1996-04-23 1997-04-18 Pyrazinone thrombin inhibitors

Publications (1)

Publication Number Publication Date
ATE209191T1 true ATE209191T1 (de) 2001-12-15

Family

ID=27268274

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97918780T ATE209191T1 (de) 1996-04-23 1997-04-18 Parazinon thrombin inhibitoren

Country Status (21)

Country Link
EP (1) EP0900207B1 (de)
JP (1) JP3140790B2 (de)
KR (1) KR20000010650A (de)
AT (1) ATE209191T1 (de)
AU (1) AU714985B2 (de)
BG (1) BG102948A (de)
BR (1) BR9708859A (de)
CA (1) CA2252964A1 (de)
CZ (1) CZ340898A3 (de)
DE (1) DE69709727T2 (de)
EE (1) EE9800353A (de)
HR (1) HRP970211A2 (de)
IL (1) IL126404A0 (de)
IS (1) IS4853A (de)
NO (1) NO984928L (de)
NZ (1) NZ331993A (de)
PE (1) PE13399A1 (de)
PL (1) PL329441A1 (de)
SK (1) SK145398A3 (de)
TR (1) TR199802133T2 (de)
WO (1) WO1997040024A1 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU746024B2 (en) * 1996-04-23 2002-04-11 Merck & Co., Inc. Pyrazinone thrombin inhibitors
ATE213495T1 (de) 1996-09-16 2002-03-15 Du Pont Pharm Co Eine resorbierbare röntgenopake markierung enthaltendes chirurgisches implantat und verfahren zum verriegeln desselben in einem körper
CA2283704A1 (en) * 1997-03-24 1998-10-01 Merck & Co., Inc. Thrombin inhibitors
US6011038A (en) * 1997-09-05 2000-01-04 Merck & Co., Inc. Pyrazinone thrombin inhibitors
US6147078A (en) * 1998-05-19 2000-11-14 Merck & Co., Inc. Pyrazinone thrombin inhibitors
EP1079835A4 (de) * 1998-05-19 2002-10-29 Merck & Co Inc Pyrazinone als thrombininhibitoren
JP2002516326A (ja) * 1998-05-26 2002-06-04 メルク エンド カムパニー インコーポレーテッド イミダゾピリジン系トロンビン阻害薬
EP1086122B1 (de) 1998-06-11 2005-08-24 Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Pyrazine protease inhibitore
ES2209337T3 (es) * 1998-08-14 2004-06-16 Pfizer Inc. Agentes antitromboticos.
EP1117660A4 (de) * 1998-09-28 2002-01-09 Merck & Co Inc Thrombin-inhibitoren
WO2000026210A1 (en) 1998-10-30 2000-05-11 Merck & Co., Inc. Thrombin inhibitors
US6610692B1 (en) 1998-10-30 2003-08-26 Merck & Co., Inc. Thrombin inhibitors
AU3127900A (en) 1998-12-23 2000-07-31 Du Pont Pharmaceuticals Company Thrombin or factor xa inhibitors
AR023510A1 (es) 1999-04-21 2002-09-04 Astrazeneca Ab Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina.
US6664255B1 (en) 1999-05-19 2003-12-16 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
US7015230B1 (en) 1999-05-19 2006-03-21 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade
IL146245A0 (en) * 1999-05-19 2002-07-25 Pharmacia Corp Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
US6750342B1 (en) 1999-05-19 2004-06-15 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
EP1586565A1 (de) * 1999-05-19 2005-10-19 Pharmacia Corporation Substituierte polycyclische aryl und heteroarylpyrazinone zur selektiven Hemmung von der Blutgerinnungskaskade
US6867217B1 (en) 1999-05-19 2005-03-15 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
US6458952B1 (en) 1999-05-19 2002-10-01 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade
US6716838B1 (en) 1999-05-19 2004-04-06 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents
US6653316B1 (en) 1999-05-19 2003-11-25 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
UA58636C2 (uk) * 1999-06-04 2003-08-15 Мерк Енд Ко., Інк. Піразинонові інгібітори тромбіну, фармацевтична композиція, спосіб інгібування утворення тромбів у крові, спосіб лікування станів, пов'язаних із тромбоутворенням
EP1202976B1 (de) 1999-07-19 2006-11-02 Merck Frosst Canada Ltd. Pyrazinone, diese verbindungen enthaltende zusammenstellungen
JP2003514905A (ja) 1999-11-23 2003-04-22 メルク エンド カムパニー インコーポレーテッド ピラジノン系トロンビン阻害薬
US6660885B2 (en) 2000-03-13 2003-12-09 Pharmacia Corporation Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
CA2403558A1 (en) 2000-03-23 2001-09-27 Merck & Co., Inc. Thrombin inhibitors
PT1268463E (pt) 2000-04-05 2005-05-31 Pharmacia Corp 4-pironas substituidas com arilo e heteroarilo policiclicos uteis para a inibicao selectiva da cascata de coagulacao
US6693121B2 (en) 2000-04-05 2004-02-17 Pharmacia Corporation Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade
WO2001079193A2 (en) * 2000-04-14 2001-10-25 Corvas International, Inc. Substituted hydrazinyl heteroaromatic inhibitors of thrombin
US6506761B1 (en) 2000-04-14 2003-01-14 Corvas International, Inc. Substituted hydrazinyl heteroaromatic inhibitors of thrombin
US6506760B1 (en) 2000-04-14 2003-01-14 Corvas International, Inc. Substituted hydrazinyl heteroaromatic inhibitors of thrombin
US6686484B2 (en) 2000-04-17 2004-02-03 Pharmacia Corporation Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade
EP1303510A2 (de) 2000-07-17 2003-04-23 3-Dimensional Pharmaceuticals, Inc. Cyclische oxyguanidin-pyrazinone als protease-hemmer
US6710058B2 (en) 2000-11-06 2004-03-23 Bristol-Myers Squibb Pharma Company Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
US7119094B1 (en) 2000-11-20 2006-10-10 Warner-Lambert Company Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade
WO2002042272A2 (en) 2000-11-20 2002-05-30 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
US7015223B1 (en) 2000-11-20 2006-03-21 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade
JP2005519866A (ja) 2001-10-03 2005-07-07 ファルマシア・コーポレーション 凝固カスケードの選択阻害に有用な６員複素環式化合物
EP1432687A2 (de) 2001-10-03 2004-06-30 Pharmacia Corporation Substitutierte fünfgliedrige polyzyclischen vebindungen für die selektive hemmung der koagulationskaskade
ES2334990T3 (es) 2002-02-14 2010-03-18 Pharmacia Corporation Piridinonas sustituidas como moduladores de p38 map quinasa.
GB0306615D0 (en) * 2003-03-22 2003-04-30 Astrazeneca Ab New use
EP1526131A1 (de) * 2003-10-22 2005-04-27 Graffinity Pharmaceuticals Aktiengesellschaft Aminoalkyl-Pyrazinone und -Pyridone verwendbar als Thrombininhibitoren
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
CN101243069A (zh) * 2005-06-17 2008-08-13 阿斯利康(瑞典)有限公司 凝血酶抑制剂2-氧代-1,2,5,6-四氢吡啶衍生物
WO2017067670A1 (en) 2015-10-23 2017-04-27 Pharmathen S.A. A novel process for the preparation of tryptamines and derivatives thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE71096T1 (de) * 1986-09-26 1992-01-15 Ciba Geigy Ag Aminopyrazinone und aminotriazinone.

Also Published As

Publication number Publication date
JP3140790B2 (ja) 2001-03-05
JP2000508334A (ja) 2000-07-04
BR9708859A (pt) 1999-08-03
IS4853A (is) 1998-09-25
DE69709727T2 (de) 2002-08-08
KR20000010650A (ko) 2000-02-25
PE13399A1 (es) 1999-02-11
EP0900207B1 (de) 2001-11-21
DE69709727D1 (de) 2002-02-21
IL126404A0 (en) 1999-05-09
BG102948A (bg) 1999-11-30
SK145398A3 (en) 1999-05-07
HRP970211A2 (en) 1998-06-30
CA2252964A1 (en) 1997-10-30
EE9800353A (et) 1999-04-15
CZ340898A3 (cs) 1999-02-17
EP0900207A1 (de) 1999-03-10
NO984928D0 (no) 1998-10-22
AU714985B2 (en) 2000-01-13
WO1997040024A1 (en) 1997-10-30
AU2679997A (en) 1997-11-12
NO984928L (no) 1998-12-22
TR199802133T2 (xx) 2000-09-21
PL329441A1 (en) 1999-03-29
NZ331993A (en) 2000-04-28

Similar Documents

Publication Publication Date Title
DE69709727D1 (de) Parazinon thrombin inhibitoren
WO1996003374A1 (en) Thrombin inhibitors
ATE234091T1 (de) Thrombin inhibitoren
ATE214928T1 (de) Thrombininhibitoren
ATE291031T1 (de) Medikamenten-vorstufen für thrombin-inhibitoren
DE69828682D1 (de) Nanomolare, non-peptidische inhibitoren von cathepsin d
TR199800773T2 (xx) Trombin inhibit�rleri.
FI973282A7 (fi) Trombiinin inhibiittoreita
ID18141A (id) Inhibitor metaloprotease 1,3-diheterosiklik
ATE268781T1 (de) Thrombininhibitoren
DE69625230D1 (de) Thrombininhibitoren
EE9800044A (et) Prolüülendopeptidaasi inhibiitorid
ZA974779B (en) Thrombin inhibitors.
DE69731664D1 (de) Thrombininhibitoren
ATE227571T1 (de) Thrombin inhibitoren
ZA961276B (en) Novel thrombin inhibitors.
ECSP972090A (es) Inhibidores de trombina pirazinona